Buradasınız

Kanserden korunma

Prevention from cancer

Journal Name:

Publication Year:

Abstract (2. Language): 
Cancer is one of the most frequent reasons of death in population. Prevention from cancer is possible only by demonstrating the etiological factors and avoiding these factors. Environmental factors and hereditary factors are the main two groups leading to carcinogenesis. Smoking, type of diet, obesity, hormones, viruses, physical and chemical agents are the examples of environmental factors. Cancer may develop in chronic inflammatory diseases and in even a benign tumor. Demonstrating hereditary forms of cancer, performing specific molecular genetic analysis and genetic counseling are the most important approaches in preventing from hereditary forms of cancer.
Abstract (Original Language): 
Kanser, toplumda en fazla ölüm nedenleri içinde yer alan bir hastalık grubudur. Kanserden korunma, ancak ona neden olan faktörlerin ortaya konması ve bunlardan uzak bir yaşam ile mümkündür. Kanseri oluşturan nedenler, çevresel faktörler ve herediter nedenler olarak iki grup altında incelenebilir. Çevresel nedenlerde sigara, yenilen yiyecekler, şişmanlık, hormonlar, viruslar, fiziksel ve kimyasal ajanlar gösterilebilir. Ayrıca kanser, kronik iltihabi olaylarda ve iyi huylu tümörlerin zemininde daha sık olarak gözlenmektedir. Ailesel kanser olgularının ortaya konması, bunlara özgün moleküler genetik analizlerin yapılması ve tüm ailenin bu yönde uyarılması, herediter tipte kanserlerden korunmada en önemli yaklaşımdır.
324-326

REFERENCES

References: 

1. Harris JR, Morrow M, Banadonna G.
Cancer of the breast. In: De Vita VT,
Hellman S, Rosenberg SA (eds). Cancer,
Principles and Practice of Oncology. 4th
ed. Philadelphia: JB Lippincott Co, 1993:
1264-1332.
2. Alberts B, Johnson A, Lewis J, Raff M,
Roberts R, Walter P. Cancer. In: Alberts B,
Johnson A, Lewis J, Raff M, Roberts R,
Walter P (eds). Molecular Biology of the
Cell. 4th ed. New York: Garland Science,
2002: 1313-1362.
3. Preston-Martin S, Pike MC, Ross RK,
Jones PA, Henderson BE. Increased cell
division as a cause of human cancer. Cancer
Res 1990; 50: 7415-7421.
4. Connor M, Ferguson Smith M. Cancer
genetics. In: Connor M, Ferguson Smith
M (eds). Essential Medical Genetics. 5th
ed. Oxford: Blackwell Science, 1997: 162-
176.
5. Doll FRS, Peto R. The Cases of Cancer.
New York: Oxford University Press, 1981:
38-132.
6. Travis CC, Bishop WE, Clare DP. The
genomic revolution: what does it mean for
human and ecologic risk assessment?
Ecotoxicology 2003; 12: 489-495.
7. Mea Wan H. Genetic Engineering. Dream
or Nightmare? 1st ed. Dublin: Gill and MC
Millan Ltd, 1999: 123-186.
8. Rubin H. Cancer development: the rise of
epigenetics. Eur J Cancer 1992; 28: 1-2.
9. Lemke PA, Taylor SL. Allergic Reactions
and Food Intolerance. 1st ed. New York:
Raven Press, 1994: 101-112.
10. National Academy Of Sciences, National
Research Council, Commission of Life
Sciences, Food and Nutrition Board. Diet
and health. Implications for reducing
chronic disease risk. 1st ed. Washington
DC: National Academy Press, 1989: 20-36.
11. Willet WC. Diet and human cancer. In:
Brugge J, Curran T, Harlow E (eds).
Origins of Human Cancer: A Comprehensive Review. New York: Cold Spring
Harbor Lab Pres, 1991: 19-23.
12. Salute T. Yaþam Boyu Beslenme ve Diyet.
1. Baský. Istanbul: Boyut Yayýncýlýk, 1997:
33-45.
13. Henderson BE, Ross R, Bernstein L.
Estrogens as a cause of human cancer: the
Richard and Hinda Rosenthal Foundation
award lecture. Cancer Res 1988; 48: 246-
253.
14. Emery AEH, Mueller RF. Elements of
Medical Genetics. 7th ed. New York:
Churchill Livingstone Press, 1989: 77-94.
15. Hubard R. Eugenics and the human genome project. Genewatch 2000; 13: 7-8.
16. Ohlson CG, Hogstedt C. Lung cancer
among asbestos cement workers. A
Swedish cohort study and a review. Br J Ind
Med 1985; 42: 397-402.
17. Selikoff IJ, Hammond EC, Churg J.
Asbestos exposure, smoking, and neoplasia.
JAMA 1968; 204: 106-112.
18. Haim S, Mitelman F. Cancer Cytogenetics.
2nd ed. New York: Wiley Liss Inc, 1995: 5-
18.
19. Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers.
Nature 1997; 386: 761, 763.
20. Vogelstain B, Kinxler KW. The Genetics of
Cancer. 1st ed. New York: McGraw Hill
Co, 1997: 18-56.
21. Sack HG. Medical Genetics. 1st ed. New
York: Mc Graw Hill Co, 1999: 48-62.
22. Güran Þ, Tunca Y, Ýmirzalioðlu N.
Hereditary TP53 codon 292 and somatic
P16INK4A codon 94 mutations in a LiFraumeni syndrome family. Cancer Genet
Cytogenet 1999; 113: 145-151.

Thank you for copying data from http://www.arastirmax.com